While it was well-established that 1,25(OH)2D3 substantially increases serum calcium and phosphorus concentrations, Sowers et al., through a rodent study in 1980, demonstrated that hypercalcemia suppresses TSH and thyrotropin-releasing hormone (TRH) production via dopaminergic inhibition [25]. This evidence concerns the gene TRH and hypercalcemia disease.